Examine the data and tweets to deduce if the closing price of $gild will boost or lower at 2017-10-30. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-10-16,1.5,1.6,-0.5,-1.5,-1.5,2.1,2.7,2.9,3.1,3.2,3.5
2017-10-17,-0.3,0.6,-0.8,0.4,0.4,1.0,2.0,2.3,2.6,2.7,3.0
2017-10-18,0.3,1.0,-0.3,-0.3,-0.3,0.7,2.0,2.2,2.7,2.8,3.2
2017-10-19,-0.1,1.1,-1.3,2.0,2.0,-1.2,-0.2,0.3,0.7,0.8,1.1
2017-10-20,0.9,0.9,-0.9,-0.5,-0.5,-0.8,0.1,0.8,1.0,1.2,1.4
2017-10-23,1.3,1.4,-0.1,-1.3,-1.3,0.6,1.2,1.8,2.1,2.4,2.6
2017-10-24,0.1,0.3,-1.6,-0.1,-0.1,0.6,0.9,1.7,2.0,2.4,2.5
2017-10-25,0.2,0.2,-1.5,-0.3,-0.3,0.9,0.8,1.7,2.0,2.5,2.6
2017-10-26,0.5,2.1,-1.1,-2.5,-2.5,2.5,3.0,3.9,4.4,4.9,5.1
2017-10-27,-2.7,0.2,-5.6,-1.0,-1.0,2.5,3.6,4.5,5.3,5.7,6.0

2017-10-16: $gild may earn a feeler too; held the 50sma, will see if it gets down to re-test prior resistance |$gild #gilead: my only 'buy 'til you die' #investment, a deep due diligence dive  $ibb $xbi #stocks #
2017-10-17: merck $mrk remains weak from mid sept'. f' pe 15s, yield 3.0%. there are better alternatives. i favour $gild pe 10s¡­ |a few decent support plays out there too: $cdev, $czz, $gild oversold into 50sma-
2017-10-18: #options #maxpain chart for $gild. free options app  |rt AT_USER fda approves a game-changing treatment for blood cancer  $gild yescarta|rt AT_USER fda approves a game-changing treatment for blood can
2017-10-19: rt AT_USER #nih #nci $gild $nvs #cancer #pharma #biotech |rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg¡­|#nih #
2017-10-20: gilead sciences, inc. $gild given hold rating at maxim group |next thursday is the big earning day, so many big tech companies will report, $googl $amzn $msft $intc $gild $celg, $fslr, etc.|10/20/17 v
2017-10-21: rt AT_USER #earnings $amd $amzn $googl $msft $v $ba $intc $mcd $cat $hal $cmg $stx $lmt $t $has $gm $f $bidu $twtr $gild $celg  |rt AT_USER #earnings $amd $amzn $googl $msft $v $ba $intc $mcd $cat $ha
2017-10-22: bullish swing trade setups for mon, oct 23 include $wfc $baba $schw $gild $qcom  #stocks |gilead sciences $gild is s/t choppy. fpe 11, net margin 42.9%. earnings oct'26th. bullish &gt;90 to 110 by mid
2017-10-23: rt AT_USER how much is hiv cure worth alone $gild /$sgmo |$teva closed at $14.54! what an #allergan nightmare! $agn $amzn $aapl $brk $crm $cmg $dis $exel $f $googl $gild¡­ |ibd's no. 2 group tested as
2017-10-24: $gild $ahgif gilead sciences to report q3 , alternate health corp. projected $75m in revenue for the next 12 months |$gild $ahgif gilead sciences to report q3 , alternate health corp. projected $75m i
2017-10-25: #allergan #botox injector promoting #botox for depression while still unapproved in clinical trials AT_USER $agn¡­ |AT_USER if $gild can pay 12b for $kite, then why not $sgmo?  far more options with z
2017-10-26: rt AT_USER $gild said there will be an update of zuma-1 and zuma-3 at #ash17.|rt AT_USER $bmy says indirect nash markers like liver fat won¡¯t be enough. biopsy will be necessary as an endpoint in pha
2017-10-27: gilead sciences, inc. $gild issues quarterly  earnings results, beats expectations by $0.14 eps |gilead sciences, inc. $gild issues quarterly  earnings results, beats expectations by $0.14 eps |what a
2017-10-28: check this out! $tst $agn $vrx $twtr $ibm $pep $ko $hlf $gild $aapl $amzn $jnj $teva $dis $myl $mrk #allergan $brk¡­ |fyi!  $amzn $aapl $agn $myl $vrx $twtr $mrk $gild $brk $googl $iep $snap $ipxl $ms
2017-10-29: AT_USER AT_USER i do not expect $gild to pick up $blcm - gilead competitors in cart are being extremely¡­ |$gild had good earnings. m/t bullish to $110 and beyond. fpe 10s. nm 44.4%. arguably, the bes
Answer:
Examine the data and tweets to deduce if the closing price of $gild will boost or lower at 2017-10-30. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-10-16,1.5,1.6,-0.5,-1.5,-1.5,2.1,2.7,2.9,3.1,3.2,3.5
2017-10-17,-0.3,0.6,-0.8,0.4,0.4,1.0,2.0,2.3,2.6,2.7,3.0
2017-10-18,0.3,1.0,-0.3,-0.3,-0.3,0.7,2.0,2.2,2.7,2.8,3.2
2017-10-19,-0.1,1.1,-1.3,2.0,2.0,-1.2,-0.2,0.3,0.7,0.8,1.1
2017-10-20,0.9,0.9,-0.9,-0.5,-0.5,-0.8,0.1,0.8,1.0,1.2,1.4
2017-10-23,1.3,1.4,-0.1,-1.3,-1.3,0.6,1.2,1.8,2.1,2.4,2.6
2017-10-24,0.1,0.3,-1.6,-0.1,-0.1,0.6,0.9,1.7,2.0,2.4,2.5
2017-10-25,0.2,0.2,-1.5,-0.3,-0.3,0.9,0.8,1.7,2.0,2.5,2.6
2017-10-26,0.5,2.1,-1.1,-2.5,-2.5,2.5,3.0,3.9,4.4,4.9,5.1
2017-10-27,-2.7,0.2,-5.6,-1.0,-1.0,2.5,3.6,4.5,5.3,5.7,6.0

2017-10-16: $gild may earn a feeler too; held the 50sma, will see if it gets down to re-test prior resistance |$gild #gilead: my only 'buy 'til you die' #investment, a deep due diligence dive  $ibb $xbi #stocks #
2017-10-17: merck $mrk remains weak from mid sept'. f' pe 15s, yield 3.0%. there are better alternatives. i favour $gild pe 10s¡­ |a few decent support plays out there too: $cdev, $czz, $gild oversold into 50sma-
2017-10-18: #options #maxpain chart for $gild. free options app  |rt AT_USER fda approves a game-changing treatment for blood cancer  $gild yescarta|rt AT_USER fda approves a game-changing treatment for blood can
2017-10-19: rt AT_USER #nih #nci $gild $nvs #cancer #pharma #biotech |rt AT_USER most interesting new info in fda $gild car-t approval pr is probably this soon-to-be released comprehensive policy for reg¡­|#nih #
2017-10-20: gilead sciences, inc. $gild given hold rating at maxim group |next thursday is the big earning day, so many big tech companies will report, $googl $amzn $msft $intc $gild $celg, $fslr, etc.|10/20/17 v
2017-10-21: rt AT_USER #earnings $amd $amzn $googl $msft $v $ba $intc $mcd $cat $hal $cmg $stx $lmt $t $has $gm $f $bidu $twtr $gild $celg  |rt AT_USER #earnings $amd $amzn $googl $msft $v $ba $intc $mcd $cat $ha
2017-10-22: bullish swing trade setups for mon, oct 23 include $wfc $baba $schw $gild $qcom  #stocks |gilead sciences $gild is s/t choppy. fpe 11, net margin 42.9%. earnings oct'26th. bullish &gt;90 to 110 by mid
2017-10-23: rt AT_USER how much is hiv cure worth alone $gild /$sgmo |$teva closed at $14.54! what an #allergan nightmare! $agn $amzn $aapl $brk $crm $cmg $dis $exel $f $googl $gild¡­ |ibd's no. 2 group tested as
2017-10-24: $gild $ahgif gilead sciences to report q3 , alternate health corp. projected $75m in revenue for the next 12 months |$gild $ahgif gilead sciences to report q3 , alternate health corp. projected $75m i
2017-10-25: #allergan #botox injector promoting #botox for depression while still unapproved in clinical trials AT_USER $agn¡­ |AT_USER if $gild can pay 12b for $kite, then why not $sgmo?  far more options with z
2017-10-26: rt AT_USER $gild said there will be an update of zuma-1 and zuma-3 at #ash17.|rt AT_USER $bmy says indirect nash markers like liver fat won¡¯t be enough. biopsy will be necessary as an endpoint in pha
2017-10-27: gilead sciences, inc. $gild issues quarterly  earnings results, beats expectations by $0.14 eps |gilead sciences, inc. $gild issues quarterly  earnings results, beats expectations by $0.14 eps |what a
2017-10-28: check this out! $tst $agn $vrx $twtr $ibm $pep $ko $hlf $gild $aapl $amzn $jnj $teva $dis $myl $mrk #allergan $brk¡­ |fyi!  $amzn $aapl $agn $myl $vrx $twtr $mrk $gild $brk $googl $iep $snap $ipxl $ms
2017-10-29: AT_USER AT_USER i do not expect $gild to pick up $blcm - gilead competitors in cart are being extremely¡­ |$gild had good earnings. m/t bullish to $110 and beyond. fpe 10s. nm 44.4%. arguably, the bes
Answer:+Fall